Article
Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder.
Clinical schizophrenia & related psychoses - 1 Jan 2000
Hirasawa-Fujita Mika, Bly Michael J, Ellingrod Vicki L, Dalack Gregory W, Domino Edward F
Abstract excerpt
It is not known why mentally ill persons smoke excessively. Inasmuch as endogenous opioid and dopaminergic systems are involved in smoking reinforcement, it is important to study mu opioid receptor (OPRM1) A118G (rs1799971), dopamine D2 receptor (DRD2) Taq1A (rs1800497) genotypes, and sex differences among patients with schizophrenia or bipolar disorder. Smokers and nonsmokers with schizophrenia (n=177) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.